Sandoz launches generic lenalidomide in 19 countries across Europe
Sandoz has announced the launch of generic oncology medicine lenalidomide, indicated for several haemato-oncology conditions as recommended by the latest European Society for Medical Oncology (ESMO) guidelines. The medicine will become available to patients in 19 countries across Europe. The cost of treating multiple myeloma patients is high and continues to rise. Affordability of and access to new multiple myeloma […]
Recent Comments